VEGFC and neoplasm: Together, these findings identify <i>miR-374b-5p</i> as a novel regulator of melanoma progression that acts through VEGFC-associated MAPK signaling and tumor microenvironment reprogramming, identifying <i>miR-374b-5p</i> as a promising therapeutic candidate for melanoma.